⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL4907735 | 0.97 | CYP2D6 (0.39) | — | |
| SCHEMBL22965641 | 0.83 | LMNA (0.38) | — | |
| SCHEMBL14951357 | 0.83 | CYP2D6 (0.31) | — | |
| SCHEMBL18553052 | 0.83 | CYP2D6 (0.31) | — | |
| SCHEMBL14074677 | 0.83 | CYP2D6 (0.31) | — | |
| SCHEMBL6279880 | 0.81 | LMNA (0.41) | — | |
| SCHEMBL18245060 | 0.80 | CYP2D6 (0.32) | — | |
| SCHEMBL12039773 | 0.79 | LMNA (0.46) | — | |
| SCHEMBL24433260 | 0.79 | LMNA (0.59) | — | |
| SCHEMBL272858 | 0.78 | TDP1 (0.36) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 331 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119751374-A | Isothiazolinone compound with high antibacterial activity and low ecological toxicity, and preparation method and application thereof | 中国科学院水生生物研究所 | 2025-04-04 | — | — | CN | claimed |
| EP-1928786-B1 | PROCESSES FOR PREPARING MTT ZEOLITES USING NITROGEN-CONTAINING ORGANIC COMPOUNDS | CHEVRON USA INC (US) | 2016-12-28 | — | — | EP | claimed |
| EP-1928786-A1 | PROCESSES FOR PREPARING MTT ZEOLITES USING NITROGEN-CONTAINING ORGANIC COMPOUNDS | Chevron U.S.A., Inc. (US) | 2008-06-11 | — | — | EP | claimed |
| WO-2007027437-A1 | PROCESSES FOR PREPARING MTT ZEOLITES USING NITROGEN-CONTAINING ORGANIC COMPOUNDS | CHEVRON U.S.A. INC. (US) | 2007-03-08 | — | — | WO | claimed |
| CN-119751374-A | Isothiazolinone compound with high antibacterial activity and low ecological toxicity, and preparation method and application thereof | 中国科学院水生生物研究所 | 2025-04-04 | — | — | CN | disclosed |
| CN-112533902-B | Composition comprising a nitroxide inhibitor, a quinone methide blocker and an amine stabilizer to inhibit polymerization of monomers | 埃科莱布美国股份有限公司 | 2025-03-14 | — | — | CN | disclosed |
| US-12036209-B2 | Compounds and methods for the targeted degradation of Interleukin-1 receptor-associated kinase 4 polypeptides | ARVINAS OPERATIONS, INC. (US) | 2024-07-16 | — | — | US | disclosed |
| CN-114456112-B | Synthesis method of benzanthracene derivative | 安徽大学 | 2024-04-12 | — | — | CN | disclosed |
| US-20230372496-A1 | TRICYCLIC HETEROBIFUNCTIONAL COMPOUNDS FOR DEGRADATION OF TARGETED PROTEINS | C4 THERAPEUTICS, INC. (US) | 2023-11-23 | — | — | US | disclosed |
| US-20230233692-A1 | COMPOUNDS FOR TARGETED DEGRADATION OF RET | C4 THERAPEUTICS, INC. (US) | 2023-07-27 | — | — | US | disclosed |
| US-20230233689-A1 | Bifunctional Small Molecules to Target the Selective Degradation of Circulating Proteins | UNIV YALE (US) | 2023-07-27 | — | — | US | disclosed |
| US-11691972-B2 | Compounds for targeted degradation of BRD9 | C4 THERAPEUTICS, INC. (US) | 2023-07-04 | — | — | US | disclosed |
| US-7186747-B2 | Compounds as inhibitors of hepatitis C virus NS3 serine protease | SCHERING CORPORATION (US) | 2007-03-06 | — | — | US | disclosed |
| US-7157075-B1 | Process for preparing MTT zeolites using nitrogen-containing organic compounds | CHEVRON U.S.A. INC. (US) | 2007-01-02 | — | — | US | disclosed |
| US-7157075-B1 | Process for preparing MTT zeolites using nitrogen-containing organic compounds | CHEVRON U.S.A. INC. (US) | 2007-01-02 | — | — | US | disclosed |
| WO-2006080577-A1 | INDOLE DERIVATIVES | TANABE SEIYAKU CO., LTD. (JP) | 2006-08-03 | — | — | WO | disclosed |
| US-20060154866-A1 | Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level | ARENA PHARMACEUTICALS, INC. | 2006-07-13 | — | — | US | disclosed |
| EP-0838508-B1 | Aqueous ink composition for use in an ink-jet printer | SEIKO EPSON CORP (JP) | 2001-08-29 | — | — | EP | disclosed |
| US-5871572-A | COLORANT, WATER, A WATER-SOLUBLE ORGANIC SOLVENT, AND PECTIC ACID | SEIKO EPSON CORPORATION (JP) | 1999-02-16 | — | — | US | disclosed |
| EP-0838508-A2 | Aqueous ink composition for use in an ink-jet printer | SEIKO EPSON CORPORATION (JP) | 1998-04-29 | — | — | EP | disclosed |